JP Drafts (September 2020)

JP drafts for public comments, September 1 - November 30, 2020

New monographs

• Temozolomide (001-2009eng.pdf)
• Temozolomide Capsules (002-2009eng.pdf)
• Temozolomide for Injection (003-2009eng.pdf)

Ultraviolet-visible reference spectra

• Temozolomide (004-2009eng.pdf)

Infrared reference spectra

• Temozolomide (005-2009eng.pdf)

To send the comment on these drafts, the guidance is as follows:

1. Download the form for comments in  Word format
2. Fill in the form
3. Prepare and attach the supportive data that scientifically validate the comment when appropriate
4. Send it to the email address: JPdraft2009eng●pmda.go.jp

Note:
For the purpose of security, this email address is partly incorrect. Please replace ● with @ when sending an email.

Related Information

• Columns (Chemical drug)

Note:
The information submitted with the comments may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).
Your comments will be considered for the preparation of JP final drafts, but no individual response will be made to each comment.